Insider transactions

EDGAR

SBC Medical Group Holdings Incorporated

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
3 transactions, 7,987,900 shares
Sum of shares × price per share: 20,151,760.5

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–5 of 5

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-04-28 Filed 2026-04-29Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)465,0003.0225
1,405,462.5

Derived: shares × price per share. Exact value 1405462.5000.

78,839,460Direct (D) No
F1
  • F1 The price of $3.0225 represents the net price received per share of common stock of SBC Medical Group Holdings Incorporated (SBC shares), which were sold by the Reporting Person, on the closing date of April 28, 2026, pursuant to the underwriters' option to purchase additional shares in connection with an underwritten public offering that initially closed on April 21, 2026.
Open filing 0001493152-26-019703 Read from the filing’s XML Dispute this row
2026-04-21 Filed 2026-04-23Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,100,0003.0225
9,369,750

Derived: shares × price per share. Exact value 9369750.0000.

79,304,460Direct (D) No
F1
  • F1 The price of $3.0225 represents the net price received per share of common stock of SBC Medical Group Holdings Incorporated (SBC shares), which were sold by the Reporting Person pursuant to an underwritten public offering that closed on April 21, 2026.
Open filing 0001493152-26-018813 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-10Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,422,9002.12
9,376,548

Derived: shares × price per share. Exact value 9376548.00.

861,600Indirect (I) By Aikawa Equity Management Co., Ltd.No
F1, F2, F3, F4
  • F1 Reflects the sale pursuant to separate share purchase agreements (the Purchase Agreements) by the Reporting Person of shares of Aikawa Equity Management Co., Ltd. (AEM) to certain consultants providing services to medical corporations that have entered into contractual and service arrangements with subsidiaries of the Issuer. AEM directly holds 5,284,500 shares of Issuer common stock (SBC shares), and each share of AEM corresponds to one hundred SBC shares. The number reported reflects the number of SBC shares held by AEM that corresponds with AEM shares sold by the Reporting Person as described above. No actual SBC shares were sold by the Reporting Person or AEM.
  • F2 The sales price reported herein is based on the JPY 33,417 price per AEM share, divided by 100 and converted from Japanese yen to United States dollars at an exchange rate of JPY 157.640= US$1.00, which was the foreign exchange rate on March 6, 2026, as reported by the U.S. Federal Reserve in its weekly release on March 9, 2026.
  • F3 Reflects the transfer of 5,284,500 and 5,000,000 SBC shares by the Reporting Person to each of AEM and GODO Kaisha Aikawa Investment (GODO), respectively, each of which was a wholly owned subsidiary of the Reporting Person at the time of such transfer. As a result of the sales pursuant to the Purchase Agreements, the Reporting Person no longer controls AEM, and therefore, disclaims beneficial ownership over the SBC shares held by AEM, except to the extent of his pecuniary interest therein.
  • F4 The 861,600 SBC shares reported as indirectly beneficially owned by the Reporting Person through AEM reflects the Reporting Person's indirect interest that he may be deemed to have shared beneficial ownership over following the transactions described herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
Open filing 0001493152-26-009608 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-10Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
J

Other acquisition or disposition (describe transaction)

Derivative security: Put Options (Right to Sell) — underlying Common Stock (4,422,900) — exercise price 2.12
Disposed (D)44,229——44,229Indirect (I) By Aikawa Equity Management Co., Ltd.No
F2, F5, F1
  • F2 The sales price reported herein is based on the JPY 33,417 price per AEM share, divided by 100 and converted from Japanese yen to United States dollars at an exchange rate of JPY 157.640= US$1.00, which was the foreign exchange rate on March 6, 2026, as reported by the U.S. Federal Reserve in its weekly release on March 9, 2026.
  • F5 In connection with the sales described herein, pursuant to the terms of the Purchase Agreements, if the price per SBC share falls below a certain price threshold on or after April 1, 2029, the consultants described above may request the Reporting Person to redeem all shares for the same amount as the purchase price described above.
  • F1 Reflects the sale pursuant to separate share purchase agreements (the Purchase Agreements) by the Reporting Person of shares of Aikawa Equity Management Co., Ltd. (AEM) to certain consultants providing services to medical corporations that have entered into contractual and service arrangements with subsidiaries of the Issuer. AEM directly holds 5,284,500 shares of Issuer common stock (SBC shares), and each share of AEM corresponds to one hundred SBC shares. The number reported reflects the number of SBC shares held by AEM that corresponds with AEM shares sold by the Reporting Person as described above. No actual SBC shares were sold by the Reporting Person or AEM.
Open filing 0001493152-26-009608 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-10Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
J

Other acquisition or disposition (describe transaction)

Derivative security: Call Options (Right to Buy) — underlying Common Stock (4,422,900) — exercise price 2.12
Acquired (A)44,229——44,229Indirect (I) By Aikawa Equity Management Co., Ltd.No
F2, F6, F1
  • F2 The sales price reported herein is based on the JPY 33,417 price per AEM share, divided by 100 and converted from Japanese yen to United States dollars at an exchange rate of JPY 157.640= US$1.00, which was the foreign exchange rate on March 6, 2026, as reported by the U.S. Federal Reserve in its weekly release on March 9, 2026.
  • F6 In connection with the sales described herein, pursuant to the terms of the Purchase Agreements, upon satisfaction of certain conditions, the Reporting Person has the right to repurchase the AEM shares from the consultants (which were acquired as described above) for the same amount as the purchase price described above.
  • F1 Reflects the sale pursuant to separate share purchase agreements (the Purchase Agreements) by the Reporting Person of shares of Aikawa Equity Management Co., Ltd. (AEM) to certain consultants providing services to medical corporations that have entered into contractual and service arrangements with subsidiaries of the Issuer. AEM directly holds 5,284,500 shares of Issuer common stock (SBC shares), and each share of AEM corresponds to one hundred SBC shares. The number reported reflects the number of SBC shares held by AEM that corresponds with AEM shares sold by the Reporting Person as described above. No actual SBC shares were sold by the Reporting Person or AEM.
Open filing 0001493152-26-009608 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Yoshiyuki Aikawa Common Stock, $0.0001 par value per share82.284,304,460.0004/19/2026 Filed 2026-04-21SCHEDULE 13D/AAmendment 3Open filing 0001493152-26-018402 Dispute this row
Aikawa Equity Management Co., Ltd. Common Stock, $0.0001 par value per share5.25,284,500.0003/06/2026 Filed 2026-03-13SCHEDULE 13GOpen filing 0001493152-26-010132 Dispute this row
Yoshiyuki Aikawa Common Stock, $0.0001 par value per share85.287,404,460.0003/06/2026 Filed 2026-03-10SCHEDULE 13D/AAmendment 2Open filing 0001493152-26-009606 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,308,615 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201516,737
2016204,955
2017207,865
2018202,770
2019215,153
2020144,184
2021224,474
2022158,941
2023199,811
2024209,823
2025235,520
2026260,174

Filings made before the SEC required XML are listed, not extracted.

Back to SBC Medical Group Holdings Incorporated